A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women
Interventions: DRUG: Letrozole|DRUG: Tamoxifen
Sponsor: Novartis Pharmaceuticals
Collaborators: Danish Breast Cancer Cooperative Group|University of Sheffield